Back to Search Start Over

Is cardioprotection with GLP-1 receptor agonists a class effect?

Authors :
Linda Mellbin
Giulia Ferrannini
Lars Rydén
Source :
European journal of preventive cardiology. 28(1)
Publication Year :
2021

Subjects

Subjects :
Cardioprotection
Epidemiology
business.industry
Glucagon-Like Peptide 1
Medicine
Humans
Hypoglycemic Agents
Class effect
Pharmacology
Cardiology and Cardiovascular Medicine
business
Glucagon-like peptide 1 receptor
Glucagon-Like Peptide-1 Receptor

Details

ISSN :
20474881
Volume :
28
Issue :
1
Database :
OpenAIRE
Journal :
European journal of preventive cardiology
Accession number :
edsair.doi.dedup.....a887a0998cac3ec8e5a75e2cdf8db419

Tools

Authors Abstract Subjects Details